Antibody CP9/19 recognises only the intra-strand cross-links formed by cisplatin between adjacent purines.
| Inventor | Institute |
|---|---|
| Michael Tilby | The Institute of Cancer Research; Newcastle University |
| Cat. #: | 151464 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Genetics |
| Application: | ELISA ; FACS ; IHC ; IP ; DB |
| Target: | Cisplatin modified native DNA |
| Clone: | CP9/19 |
| Host: | Rat |
| Class: | Monoclonal |
| Product description: | Antibody CP9/19 recognises only the intra-strand cross-links formed by cisplatin between adjacent purines. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Immunogen: | Cisplatin modified native DNA |
| Myeloma used: | Y3.AG.1.2.3 |
| Target background: | This antibody enables the quantification of cisplatin-induced adducts on DNA. This antibody has also been recently used for isolation of DNA fragments carrying adducts to enhance the sensitivity of subsequent PCR-based analyses and is central to ongoing studies of variation in the nature of cisplatin adducts formed in different cell lines. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Powell et al. 2015. Sci Rep. 5:7975. PMID: 25609656. 3D-DIP-Chip: a microarray-based method to measure genomic DNA damage. Kothandapani et al. 2012. Exp Cell Res. 318(16):1973-86. PMID: 22721696. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Kothandapani et al. 2011. J Biol Chem. 286(16):14564-74. PMID: 21357694. Novel role of base excision repair in mediating cisplatin cytotoxicity. Meczes et al. 2005. Biochem Pharmacol. 70(12):1… |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.